Liquidia Corp — Director's Dealing 2021

Nov 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2021-11-10

Reporting Person: Kaseta Michael (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-10	Common Stock	M	9250	—	Acquired	9250	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-10	Performance Stock Units	$	A	9250	Disposed		Common Stock (9250)	Direct

Footnotes

F1: Each performance stock unit (PSU) converts into one share of common stock of the Issuer.

F2: On January 19, 2021, the reporting person was granted 9,250 PSUs, vesting in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861.